Do Symptoms Improve After the Trial Phase of Sacral Nerve Stimulation?
Yes, symptoms typically continue to improve or remain stable after the trial phase in patients who proceed to permanent SNS implantation, with approximately 89% maintaining therapeutic success at 5 years and 71% at long-term follow-up beyond 5 years.
Understanding the SNS Trial-to-Permanent Transition
The trial phase serves as a critical selection tool. During the 2-3 week temporary stimulation period, patients who achieve ≥50% reduction in fecal incontinence episodes are considered candidates for permanent implantation 1. In the pivotal US multicenter trial, 90% of patients (120 of 133) who had successful trial stimulation proceeded to permanent implantation 1.
Long-Term Outcomes After Permanent Implantation
Short to Medium-Term Results (1-5 Years)
- At 12 months post-permanent implantation, 71% of patients maintained ≥50% reduction in FI frequency 1
- Among 76 of 120 patients (63%) with 5-year follow-up data, 36% reported complete continence and 89% were deemed a therapeutic success 1
Extended Long-Term Results (Beyond 5 Years)
In a large European cohort of 228 patients followed for a median of 84 months (approximately 7 years):
- Long-term success (≥50% symptom improvement) was maintained in 71.3% of patients in per-protocol analysis 2
- Full continence was achieved in 50% of patients 2
- Defecation frequency improvements persisted (from median 7 to 0.25 FI episodes per week) 2
- Cleveland Clinic scores remained significantly improved (from 16 at baseline to 7 at long-term follow-up) 2
Another long-term study with median 110-month follow-up demonstrated that approximately 60% of patients maintained improvement, though there was some reduction in efficacy over time 3.
Key Clinical Insights
The Trial Phase as Predictor
The magnitude of improvement during the trial phase correlates with long-term success 2. Patients with minor symptom improvement during temporary testing had higher risk of long-term failure. This means the trial phase response is generally maintained or slightly improved after permanent implantation in successful candidates.
Quality of Life Improvements
Beyond symptom reduction, patients experience sustained improvements in:
- All four domains of fecal incontinence quality of life scores 1
- Incontinence-free days (significantly increased compared to baseline) 1
- Patient satisfaction (80% satisfied at last follow-up in one series) 4
Important Caveats
Device-Related Issues
- Batteries require replacement approximately every 7 years 1
- Pain and infection at insertion site occur in up to 10% of patients 1
- Revision rates range from 7.5-15% for issues including lead migration (33%), pain (33%), connection failure (20%), and rarely infection (6.7%) 5
The Paradox of Mechanism
Interestingly, six crossover studies showed patients experienced equal symptoms with the stimulator on or off 1. This puzzling finding suggests the mechanism may involve neuroplastic changes or colonic motility alterations rather than direct continuous stimulation effects.
Realistic Expectations
While complete continence is achieved in 36-50% of patients long-term 1, 2, most patients experience significant but not complete resolution. The improvement seen during the trial phase generally represents what patients can expect long-term, though some attenuation may occur after 5+ years 3.
Clinical Algorithm for Patient Counseling
If trial phase shows ≥50% improvement:
- Proceed to permanent implantation
- Expect similar or slightly better results initially
- Anticipate 89% therapeutic success at 5 years
- Anticipate 71% success beyond 5 years
- Plan for battery replacement at 7 years
If trial phase shows <50% improvement:
- Do not proceed to permanent implantation
- Consider alternative therapies
The evidence consistently demonstrates that symptoms do not deteriorate after transitioning from trial to permanent SNS; rather, the improvement achieved during the trial phase is generally maintained long-term in appropriately selected patients 1, 6, 2, 4, 3.